Abstract:NK cells contribute to early defenses against viruses through their inborn abilities that include sensing of PAMPs and inflammatory signals such as cytokines or chemokines, recognition, and killing of infected cells through activating surface receptors engagement. Moreover, they support adaptive responses via Ab-dependent mechanisms, triggered by CD16, and DC editing. Their fundamental role in anti-viral responses has been unveiled in patients with NK cell deficiencies suffering from severe Herpesvirus infections. Notably, these infections, often occurring as primary infections early in life, can be efficiently cleared by NK, T, and B cells in healthy hosts. Herpesviruses however, generate a complicated balance with the host immune system through their latency cycle moving between immune control and viral reactivation. This lifelong challenge has contributed to the development of numerous evasion mechanisms by Herpesviruses, many of which devoted to elude NK cell surveillance from viral reactivations rather than primary infections. This delicate equilibrium can be altered in proportions of healthy individuals promoting virus reactivation and, more often, in immunocompromised subjects. However, the constant stimulus provided by virus-host interplay has also favored NK-cell adaptation to Herpesviruses. During anti-HCMV responses, NK cells can reshape their receptor repertoire and function, through epigenetic remodeling, and acquire adaptive traits such as longevity and clonal expansion abilities. The major mechanisms of recognition and effector responses employed by NK cells against Herpesviruses, related to their genomic organization will be addressed, including those allowing NK cells to generate memory-like responses. In addition, the mechanisms underlying virus reactivation or control will be discussed.

Natural killer cell specificity for viral infections

Natural killer cells in antiviral immunity

Natural killer cells play an important role in virus infection control: Antiviral mechanism, subset expansion and clinical application

Editorial: Natural Killer Cell Plasticity and Diversity in Antiviral Immunity

Viral Evasion of Natural Killer Cell Activation

Innate or Adaptive Immunity? The Example of Natural Killer Cells

NK-cell receptor modulation in viral infections

Role of Natural Cytotoxicity Receptors of NK Cells in Tumor and Vi-rus Infection

Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors

The Natural Cytotoxicity Receptors in Health and Disease

The immune environment dictates the dominance of licensed versus unlicensed natural killer cell subsets during viral infection

Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications

Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation

Human NK cells, their receptors and function

CD49a+CD49b+ NK cells induced by viral infection reflect an activated state of conventional NK cells

NK cells at the interface between innate and adaptive immunity

Natural killer cell cytotoxicity and its regulation by inhibitory receptors

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)

Natural Killer Cells: Development, Maturation, and Clinical Utilization

Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization

Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells